Indefinite Delivery Contract 75F40123D00039

Award Date 9/26/23
Last Date to Order 9/29/28
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services Food and Drug Administration awarded a single award Indefinite Delivery Indefinite Quantity contract to Labstat International Inc. to provide tobacco laboratory analysis and engineering services. The contract has a potential value of $45 million over five one-year ordering periods. Three firm fixed price delivery orders have been awarded against the contract to date, including for new smoking regimen services generating and quantitating tobacco smoke...
This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to the non-profit Research Triangle Institute (RTI) International. The contract, valued up to $2,500,000, is for engineering analysis laboratory services to support the FDA's regulation of electronic cigarettes and other newly deemed tobacco products. The contract includes two firm fixed-price delivery orders issued to date. The first...
The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery/indefinite quantity multiple award contract to Research Triangle Institute to provide tobacco analysis and engineering laboratory services in support of FDA regulation of tobacco products. Task orders issued against the contract include research and analysis of nicotine salts' impact on leaching metals into e-liquids at locations in Maryland and North Carolina valued at over $45...
This indefinite delivery contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Battelle Memorial Institute, a non-profit organization and manufacturer of goods. The $10 million master IDIQ contract, titled "Tobacco Products Pharmacology Study", is focused on regulatory and scientific efforts related to tobacco products under the FDA's purview. The contract has resulted in several firm fixed-price delivery orders to Battelle, valued at...
This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the Research Triangle Institute (RTI International), a non-profit research organization. The contract has a ceiling value of $1,030,128.58 and a period of performance through October 31, 2023. The purpose of this contract is to conduct identification and validation of a biomarker of electronic cigarette exposure. This research effort will support the FDA's regulatory and...
The U.S. Food and Drug Administration (FDA), a civilian agency, awarded a $60 million single-award Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, for the evaluation of the FDA's Center for Tobacco Products' (CTP) public health education campaigns and communication programs. This contract, which does not have a set-aside designation, has an ultimate completion date of August 29, 2026. Under this IDC, RTI has been awarded...
The Department of Health and Human Services Food and Drug Administration awarded a single-award Indefinite Delivery Contract set aside for total small businesses to Mpf-Zai Solutions LLC. The contract has a potential value of $65M over five years to support the FDA Center for Tobacco Products' Office of Compliance and Enforcement. Two delivery orders have been awarded against the IDC to date. The first is a $8.5M time and materials order to process retailer compliance check inspection data and...
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to the National Academy of Sciences with a potential value of $30,000,000.00. The contract establishes a forum for the agency to convene committees for assessment, evaluations, and studies related to public health issues. Five task orders have been awarded against the contract to date, with periods of performance ranging from September 2022 through September 2025. Task orders...
The U.S. Food and Drug Administration (FDA) awarded a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract, valued at $5 million, to Labstat International Inc., a Canadian for-profit limited liability company, to provide tobacco analysis laboratory services over a 5-year period. This IDIQ contract allows the FDA to issue multiple firm fixed-price delivery orders for chemical, physical, and microbiological testing of tobacco, e-cigarette, cannabis, and CBD products in support of...
This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Northstar Technology Corp., a woman-owned small business. The contract has a total ceiling value of $1,000,000 and was set aside for the 8(a) small business program. The purpose of the contract is to acquire tobacco products for testing and analysis by the FDA. Under this IDV, Northstar has been issued several firm-fixed price delivery orders to provide a variety of tobacco...
  • 75F40123D00039
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Lovelace Biomedical Research Institute with a potential value of $25 million. To date, two firm fixed price delivery orders have been awarded against the contract.

Task Order 1, valued at $3.8 million, tasks Lovelace Biomedical Research Institute to determine if reductions in biomarkers of exposure and potential harm are proportional to reductions in cigarette smoking when switching to electronic nicotine delivery systems. The period of performance is September 2023 through March 2026 in Calverton, Maryland. Task Order 2, valued at $1.25 million, involves examining the influence of synthetic cooling agents on cigarette sensory and subjective effects and use behavior. The period of performance for Task Order 2 is September 2023 through September 2028 in Calverton, Maryland.

The original solicitation sought research assessing tobacco-related clinical outcomes and human behaviors in tobacco. Through this contract and associated task orders, the Food and Drug Administration aims to procure research and analysis to support its regulation of tobacco and electronic nicotine delivery products. Both task orders examine aspects of product use and potential health effects to inform the FDA's public health mission.

Generated 1/4/24, 11:13 PM